Dimetacrine

This classification denotes an antidepressant agent with the molecular formula C20H26N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O341NY501N, chemically known as 9,9-dimethyl-10-(3-(dimethylamino)propyl)acridan but generally known as dimetacrine, which bears US NIH Compound Identifier 94280. European Medicines Agency schedules Dimetacrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07168MIG. The term DIMETACRINE is an International Non-Proprietary Name. World Health Organization schedules dimetacrine in its Anatomical Therapeutic Chemical (ATC) Classification. DIMETACRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dimetacrine under HS 29339990 and SITC 51577. As of Q4 2014, DIMETACRINE remains the US FDA Preferred Term for this commodity. Dimetacrine bears US NLM identifiers UMLS ID C0058199 and NCI Concept Code C81490. SMILES: N1(c2c(C(c3c1cccc3)(C)C)cccc2)CCCN(C)C.